EUVIMEDEUVIMED entdecken
Crossref

Favorable outcomes in triple-negative breast cancer managed without neoadjuvant therapy

B. Mollavelioglu, B. Emiroglu, S. Bagbudar, S. Emiroglu, M. Tukenmez, N. Cabioglu, M. Muslumanoglu

European Journal of Cancer · 2026-03 · 237 · 116483

DOI: 10.1016/j.ejca.2026.116483 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-03. Verfasst von B. Mollavelioglu und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Mollavelioglu, B., Emiroglu, B., Bagbudar, S., Emiroglu, S., Tukenmez, M., Cabioglu, N., & Muslumanoglu, M. (2026). Favorable outcomes in triple-negative breast cancer managed without neoadjuvant therapy. European Journal of Cancer, 237, 116483. https://doi.org/10.1016/j.ejca.2026.116483

Vancouver

Mollavelioglu B, Emiroglu B, Bagbudar S, Emiroglu S, Tukenmez M, Cabioglu N, et al. Favorable outcomes in triple-negative breast cancer managed without neoadjuvant therapy. European Journal of Cancer. 2026;237:116483. doi:10.1016/j.ejca.2026.116483

BibTeX
@article{Mollavelioglu2026,
  author = {Mollavelioglu, B. and Emiroglu, B. and Bagbudar, S. and Emiroglu, S. and Tukenmez, M. and Cabioglu, N. and Muslumanoglu, M.},
  title = {Favorable outcomes in triple-negative breast cancer managed without neoadjuvant therapy},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {237},
  pages = {116483},
  doi = {10.1016/j.ejca.2026.116483}
}
Kostenlos starten →